Nature Communications (Sep 2021)

Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression

  • Sakshi Goel,
  • Vipul Bhatia,
  • Sushmita Kundu,
  • Tanay Biswas,
  • Shannon Carskadon,
  • Nilesh Gupta,
  • Mohammad Asim,
  • Colm Morrissey,
  • Nallasivam Palanisamy,
  • Bushra Ateeq

DOI
https://doi.org/10.1038/s41467-021-25623-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 22

Abstract

Read online

Distal-less homeobox 1 (DLX1) is reported as a prostate cancer (PCa) diagnostic biomarker, but the mechanism for its upregulation in PCa is unclear. Here the authors show that ERG, AR and FOXA1 transcriptionally regulates DLX1 expression in PCa, and the inhibition of this ERG/AR transcriptional circuitry with a BET inhibitor reduces the oncogenic effects of DLX1.